Practice
Stopping anticoagulation in a woman with unprovoked venous thromboembolism
Faizan Khan, Grégoire Le Gal and Marc A. Rodger
CMAJ September 05, 2017 189 (35) E1112-E1114; DOI: https://doi.org/10.1503/cmaj.170327
Faizan Khan
School of Epidemiology, Public Health & Preventive Medicine (Khan), University of Ottawa; Clinical Epidemiology Program (Khan, Le Gal, Rodger), Ottawa Hospital Research Institute; Ottawa Blood Disease Centre, Department of Medicine (Le Gal, Rodger), University of Ottawa and The Ottawa Hospital, Ottawa, Ont.
MScGrégoire Le Gal
School of Epidemiology, Public Health & Preventive Medicine (Khan), University of Ottawa; Clinical Epidemiology Program (Khan, Le Gal, Rodger), Ottawa Hospital Research Institute; Ottawa Blood Disease Centre, Department of Medicine (Le Gal, Rodger), University of Ottawa and The Ottawa Hospital, Ottawa, Ont.
MD PhDMarc A. Rodger
School of Epidemiology, Public Health & Preventive Medicine (Khan), University of Ottawa; Clinical Epidemiology Program (Khan, Le Gal, Rodger), Ottawa Hospital Research Institute; Ottawa Blood Disease Centre, Department of Medicine (Le Gal, Rodger), University of Ottawa and The Ottawa Hospital, Ottawa, Ont.
MD MScArticle Figures & Tables
There are no figures or tables available.
In this issue
Article tools
Respond to this article
Stopping anticoagulation in a woman with unprovoked venous thromboembolism
Faizan Khan, Grégoire Le Gal, Marc A. Rodger
CMAJ Sep 2017, 189 (35) E1112-E1114; DOI: 10.1503/cmaj.170327
Jump to section
- Article
- What further information is needed?
- What should this patient be told about the risk of recurrent venous thromboembolism if anticoagulation is stopped?
- Does the patient require any investigations?
- Should the patient be switched to ASA?
- What should the patient watch out for?
- Are any special precautions required for future travel?
- Case revisited
- Acknowledgement
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics